MetaADEDB 2.0 @ LMMD
Evotaz
(IFDLZKYAGSJMEM-XGEJSPNLSA-N)
Structure
SMILES
O=C(N[C@@H](Cc1ccccc1)CC[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1.COC(=O)N[C@@H](C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)C[C@@H]([C@H](Cc1ccccc1)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O
Molecular Formula:
C78H105N13O12S2
Molecular Weight:
1480.880
Log P:
12.8865
Hydrogen Bond Acceptor:
27
Hydrogen Bond Donor:
8
TPSA:
365.72
CAS Number(s):
N/A
Synonym(s)
1.
Evotaz
External Link(s)
PubChem Compound86583336
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood HIV RNA increasedFAERS: 3US FAERS
2Adverse eventFAERS: 2US FAERS
3MalaiseFAERS: 2US FAERS
4NauseaFAERS: 2US FAERS
5Ocular icterusFAERS: 2US FAERS
6jaundiceFAERS: 2US FAERS
7AstheniaFAERS: 1US FAERS
8Blood bilirubin unconjugated increasedFAERS: 1US FAERS
9Blood triglycerides increasedFAERS: 1US FAERS
10BronchitisFAERS: 1US FAERS
11DiplopiaFAERS: 1US FAERS
12Drug resistanceFAERS: 1US FAERS
13Drug screen positiveFAERS: 1US FAERS
14DysgeusiaFAERS: 1US FAERS
15DyspepsiaFAERS: 1US FAERS
16EczemaFAERS: 1US FAERS
17Erectile dysfunctionFAERS: 1US FAERS
18FlatulenceFAERS: 1US FAERS
19HeadacheFAERS: 1US FAERS
20Maternal exposure during pregnancyFAERS: 1US FAERS
21Memory impairmentFAERS: 1US FAERS
22PalpitationsFAERS: 1US FAERS
23Product storage errorFAERS: 1US FAERS
24Product use issueFAERS: 1US FAERS
25Rheumatic disorderFAERS: 1US FAERS
26Therapy changeFAERS: 1US FAERS
27Weight decreasedFAERS: 1US FAERS
28Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.